SCHEMBL13712548

SCHEMBL13712548

CC(C)(C)OC(=O)N1CC[C@H](NCC(F)F)C1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.51
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
USP30 Q70CQ3 7/20 0.46
CYP2C9 P11712 1/20 0.45
HSD11B1 P28845 1/20 0.45
HPGD P15428 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
RECQL P46063 1/20 0.42
GPR119 Q8TDV5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25706542 1.00 EPHX1 (0.51) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL2900547 0.90 EPHX1 (0.52) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL4112002 0.90 EPHX1 (0.52) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL22989923 0.90 NR1H2 (0.48) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL20267838 0.88 EPHX1 (0.58) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL3255861 0.85 EPHX1 (0.54) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL2498330 0.85 EPHX1 (0.54) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL652761 0.85 EPHX1 (0.54) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL24032924 0.84 EPHX1 (0.50) EPHX1ALDH1A1MAPTNPC1MAPK1
SCHEMBL13712536 0.84 EPHX1 (0.50) EPHX1ALDH1A1MAPTNPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026085629-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2026-04-30 WO disclosed
US-20090239929-A1 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors PFIZER INC. 2009-09-24 US disclosed
US-20090239929-A1 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors PFIZER INC. 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239929-A1 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors TPH1, TPH2, HTR1A EPHX1 856/4885ALDH1A1 891/4885MAPT 4728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.